Novel Symmetrical Cage Compounds as Inhibitors of the Symmetrical MRP4-Efflux Pump for Anticancer Therapy
Within the last decades cancer treatment improved by the availability of more specifically acting drugs that address molecular target structures in cancer cells. However, those target-sensitive drugs suffer from ongoing resistances resulting from mutations and moreover they are affected by the cance...
Main Authors: | David Kreutzer, Henry Döring, Peter Werner, Christoph A. Ritter, Andreas Hilgeroth |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/10/5098 |
Similar Items
-
Discovery of Novel Symmetrical 1,4-Dihydropyridines as Inhibitors of Multidrug-Resistant Protein (MRP4) Efflux Pump for Anticancer Therapy
by: Henry Döring, et al.
Published: (2020-12-01) -
Novel Nonsymmetrical 1,4-Dihydropyridines as Inhibitors of Nonsymmetrical MRP-Efflux Pumps for Anticancer Therapy
by: David Kreutzer, et al.
Published: (2020-07-01) -
Correction: Döring et al. Discovery of Novel Symmetrical 1,4-Dihydropyridines as Inhibitors of Multidrug-Resistant Protein (MRP4) Efflux Pump for Anticancer Therapy. <i>Molecules</i> 2021, <i>26</i>, 18
by: Henry Döring, et al.
Published: (2022-06-01) -
Anticancer and Structure Activity Relationship of Non-Symmetrical Choline Kinase Inhibitors
by: Santiago Schiaffino-Ortega, et al.
Published: (2021-08-01) -
Inhibition of the Eukaryotic 80S Ribosome as a Potential Anticancer Therapy: A Structural Perspective
by: Simone Pellegrino, et al.
Published: (2021-08-01)